Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Vesela Kostova"'
Publikováno v:
Pharmaceuticals, Vol 14, Iss 5, p 442 (2021)
Combining the selective targeting of tumor cells through antigen-directed recognition and potent cell-killing by cytotoxic payloads, antibody-drug conjugates (ADCs) have emerged in recent years as an efficient therapeutic approach for the treatment o
Externí odkaz:
https://doaj.org/article/8230ce2aaff3492fb0e8aec52f5d6ecf
Autor:
Frédéric Schmidt, Siau-Kun Bai, Vesela Kostova, Estelle Dransart, Michel Azoulay, Ludger Johannes, Jean-Claude Florent, Laura Brulle
Publikováno v:
Bioorganic and Medicinal Chemistry
Bioorganic and Medicinal Chemistry, Elsevier, 2015, 23 (22), pp.7150-7. ⟨10.1016/j.bmc.2015.10.010⟩
Bioorganic and Medicinal Chemistry, Elsevier, 2015, 23 (22), pp.7150-7157. ⟨10.1016/j.bmc.2015.10.010⟩
Bioorganic and Medicinal Chemistry, Elsevier, 2015, 23 (22), pp.7150-7. ⟨10.1016/j.bmc.2015.10.010⟩
Bioorganic and Medicinal Chemistry, Elsevier, 2015, 23 (22), pp.7150-7157. ⟨10.1016/j.bmc.2015.10.010⟩
International audience; The main drawback of the anticancer chemotherapy consists in the lack of drug selectivity causing severe side effects. The targeted drug delivery appears to be a very promising strategy for controlling the biodistribution of t